|
|
41
|
|
|
4331AN
|
|
|
XELJANZ 5MG TAB (PFI) TOFACITINIB (C)
|
|
|
TOFACITINIB
|
|
|
XELJANZ
|
|
|
60'S
|
|
|
C
|
|
|
2373.42
|
|
|
39.5571
|
|
|
5MG
|
|
|
TAB
|
|
|
0
|
|
|
BOX
|
|
|
PFI
|
|
|
PFIZER CORPORATION
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
ORAL
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|